Enigma Diagnostics appoints Dr. Lynn Busteed as Chief Executive Officer
Enigma diagnostics announced the appointment of Dr Lynn Busteed as Chief Executive Officer (CEO) and a member of the Board of Directors. This appointment completes Enigma Diagnostics' executive management team following the recent appointments of Biresh Roy as Chief Financial Officer and Mo Aslam as Programme Director.
Dr Busteed has more than 15 years experience in the life sciences sector, specialising in corporate and business development, strategic planning and operations. She joins Enigma from Focus Diagnostics, Inc., a US-based company providing products and services for the diagnosis of infectious diseases. At Focus Diagnostics, Dr Busteed was Vice President for Corporate Development with responsibility for a broad range of business development, licensing and M&A activities and a particular emphasis on acquisition of platforms and technology to fuel growth of the diagnostics products business.
From 2001 to 2004, Dr Busteed was Senior Director, Business Development and Strategic Planning at US company Celera Genomics Group (NYSE:CRA), a leader in the field of targeted medicine based on its genomics, proteomics and molecular diagnostics businesses.
Prior to this she spent seven years at management consulting firm McKinsey & Company in France and the UK where she gained broad experience in both strategic and operational consulting focusing on healthcare, chemicals and basic materials industries.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
